Quantitation of TGF-β proteins in mouse tissues shows reciprocal changes in TGF-β1 and TGF-β3 in normal vs neoplastic mammary epithelium

Abstract

// Kathleen C. Flanders 1, * , Yu-an Yang 1, * , Michelle Herrmann 1 , JinQiu Chen 1 , Nerissa Mendoza 2 , Amer M. Mirza 2 , Lalage M. Wakefield 1 1 Laboratory of Cancer Biology and Genetics, National Cancer Institute, Bethesda, Maryland, United States of America 2 XOMA Corporation, Berkeley, California, United States of America * These authors have contributed equally to this work Correspondence to: Kathleen C. Flanders, e-mail: flanderk@mail.nih.gov Keywords: TGF-β isoforms, protein, quantitation, mouse tissues, mammary gland Received: October 28, 2015     Accepted: April 26, 2016     Published: May 17, 2016 ABSTRACT Transforming growth factor-βs (TGF-βs) regulate tissue homeostasis, and their expression is perturbed in many diseases. The three isoforms (TGF-β1, -β2, and -β3) have similar bioactivities in vitro but show distinct activities in vivo. Little quantitative information exists for expression of TGF-β isoform proteins in physiology or disease. We developed an optimized method to quantitate protein levels of the three isoforms, using a Luminex® xMAP®-based multianalyte assay following acid-ethanol extraction of tissues. Analysis of multiple tissues and plasma from four strains of adult mice showed that TGF-β1 is the predominant isoform with TGF-β2 being ~10-fold lower. There were no sex-specific differences in isoform expression, but some tissues showed inter-strain variation, particularly for TGF-β2. The only adult tissue expressing appreciable TGF-β3 was the mammary gland, where its levels were comparable to TGF-β1. In situ hybridization showed the luminal epithelium as the major source of all TGF-β isoforms in the normal mammary gland. TGF-β1 protein was 3-8-fold higher in three murine mammary tumor models than in normal mammary gland, while TGF-β3 protein was 2-3-fold lower in tumors than normal tissue, suggesting reciprocal regulation of these isoforms in mammary tumorigenesis.